Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: is dosing in the evening better than in the morning?

被引:23
作者
Burnier, Michel [1 ]
Kreutz, Reinhold [2 ,3 ,4 ]
Narkiewicz, Krzysztof [5 ]
Kjeldsen, Sverre [6 ]
Oparil, Suzanne [7 ]
Mancia, Giuseppe [8 ]
机构
[1] CHU Vaudois, Serv Nephrol & Hypertens, Lausanne, Switzerland
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[4] Berlin Inst Hlth, Inst Klin Pharmakol & Toxikol, Berlin, Germany
[5] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[6] Univ Oslo, Ullevaal Hosp, Dept Cardiol, Oslo, Norway
[7] Univ Alabama Birmingham, Dept Med, Vasc Biol & Hypertens Programme, Birmingham, AL 35294 USA
[8] Univ Milano Bicocca, Milan, Italy
关键词
bedtime; clinical trials; dipping; drug administration; nocturnal blood pressure; CONVERTING-ENZYME-INHIBITOR; CHRONIC KIDNEY-DISEASE; HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; PROGNOSTIC VALUE; GENERAL-POPULATION; SLEEP-APNEA; CARDIORENAL PROTECTION; THERAPEUTIC TARGET; ACTIVE TREATMENT;
D O I
10.1097/HJH.0000000000002532
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Blood pressure (BP) follows a circadian rhythm with a physiological decrease during the night. Studies have demonstrated that nocturnal BP as well as its dipping pattern during night-time have a significant prognostic importance for mortality and the occurrence of cardiovascular events. Therefore, hypertension management guidelines recommend to ascertain that patients treated for hypertension have well controlled BP values around the clock. To improve hypertension control during the night and eventually further reduce cardiovascular events, it has been proposed by some to prescribe at least one antihypertensive medication at bedtime. In this review, we have examined the data which could support the benefits of prescribing BP-lowering drugs at bedtime. Our conclusion is that there is no convincing evidence that the administration of BP-lowering drugs in the evening provides any significant advantage in terms of quality of BP control, prevention of target organ damage or reduction of cardiovascular events. Before changing practice for unproven benefits, it would be wise to wait for the results of the ongoing trials that are addressing this issue.
引用
收藏
页码:1396 / 1406
页数:11
相关论文
共 100 条
  • [51] Prognostic significance of night-time, early morning, and daytime blood pressures on the risk of cerebrovascular and cardiovascular mortality: the Ohasama Study
    Metoki, Hirohito
    Ohkubo, Takayoshi
    Kikuya, Masahiro
    Asayama, Kei
    Obara, Taku
    Hara, Azusa
    Hirose, Takuo
    Hashimoto, Junichiro
    Totsune, Kazuhito
    Hoshi, Haruhisa
    Satoh, Hiroshi
    Imai, Yutaka
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 (09) : 1841 - 1848
  • [52] Middeke M, 1996, Z KARDIOL, V85, P99
  • [53] MILLARCRAIG MW, 1978, LANCET, V1, P795
  • [54] Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: An 8-week uncontrolled trial
    Minutolo, Roberto
    Gabbai, Francis B.
    Borrelli, Silvio
    Scigliano, Raffaele
    Trucillo, Paolo
    Baldanza, Diego
    Laurino, Simona
    Mascia, Sara
    Conte, Giuseppe
    De Nicola, Luca
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 50 (06) : 908 - 917
  • [55] The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night
    Morgan, T
    Anderson, A
    Jones, E
    [J]. JOURNAL OF HYPERTENSION, 1997, 15 (02) : 205 - 211
  • [56] Cardiac hypertrophy depends upon sleep blood pressure: a study in rats
    Morgan, TO
    Brunner, HR
    Aubert, JF
    Wang, Q
    Griffiths, C
    Delbridge, L
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 (04) : 445 - 451
  • [57] Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study
    Mori, Hisao
    Yamamoto, Hareaki
    Ukai, Hiroshi
    Yuasa, Shouhei
    Nakajima, Kazumi
    Mikawa, Takehiko
    Niizuma, Masamichi
    Hirao, Kouichi
    Umemura, Satoshi
    [J]. HYPERTENSION RESEARCH, 2013, 36 (03) : 202 - 207
  • [58] Nold, 1998, Blood Press Monit, V3, P17
  • [59] OBRIEN E, 1988, LANCET, V2, P397
  • [60] Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study
    Ohkubo, T
    Hozawa, A
    Yamaguchi, J
    Kikuya, M
    Ohmori, K
    Michimata, M
    Matsubara, M
    Hashimoto, J
    Hoshi, H
    Araki, T
    Tsuji, I
    Satoh, H
    Hisamichi, S
    Imai, Y
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (11) : 2183 - 2189